NCT04035486 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 279
- group Id
- BG003
- value
- 278
- group Id
- BG004
- value
- 587
- units
- Participants
- groups
- description
- Osimertinib (AZD9291) 80 mg once daily (QD) with Carboplatin (AUC of 5 mg/mL/min \[AUC5\]) and Pemetrexed (500 mg/m2), both administered every 3 weeks (Q3W) for 4 cycles, followed by Osimertinib 80 mg once daily plus Pemetrexed maintenance (500 mg/m2) Q3W
- id
- BG000
- title
- Safety Run-In: AZD9291 + Carboplatin + Pemetrexed
- description
- Osimertinib (AZD9291) 80 mg once daily (QD) with Cisplatin (75 mg/m2) and Pemetrexed (500 mg/m2), both administered every 3 weeks (Q3W) for 4 cycles, followed by Osimertinib 80 mg once daily plus Pemetrexed maintenance (500 mg/m2) Q3W
- id
- BG001
- title
- Safety Run-In: AZD9291 + Cisplatin + Pemetrexed
- description
- Osimertinib (AZD9291) 80 mg in combination with pemetrexed (500 mg/m2) plus either cisplatin (75 mg/m2) or carboplatin (AUC5) on Day 1 of 21-day cycles for 4 cycles, followed by Osimertinib (AZD9291) 80 mg QD with Pemetrexed maintenance (500 mg/m2) Q3W
- id
- BG002
- title
- Randomized: AZD9291 + Chemo
- description
- Osimertinib (AZD9291) 80mg QD.
- id
- BG003
- title
- Randomized: AZD9291
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.82
- value
- 62.4
- group Id
- BG001
- spread
- 8.36
- value
- 60.4
- group Id
- BG002
- spread
- 10.03
- value
- 61.0
- group Id
- BG003
- spread
- 10.57
- value
- 60.7
- group Id
- BG004
- spread
- 10.3
- value
- 60.9
- title
- Age (Years)
- description
- Age in Years at study entry
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 88
- title
- <50
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 136
- group Id
- BG003
- value
- 122
- group Id
- BG004
- value
- 270
- title
- >=50-<65
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 82
- group Id
- BG003
- value
- 88
- group Id
- BG004
- value
- 179
- title
- >=65-<75
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 24
- group Id
- BG004
- value
- 50
- title
- >=75
- title
- Age Group
- description
- Age Groups in Years at study entry
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 173
- group Id
- BG003
- value
- 169
- group Id
- BG004
- value
- 361
- title
- Female
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 106
- group Id
- BG003
- value
- 109
- group Id
- BG004
- value
- 226
- title
- Male
- title
- Sex
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 29
- group Id
- BG004
- value
- 68
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 239
- group Id
- BG003
- value
- 248
- group Id
- BG004
- value
- 517
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 2
- title
- Unknown or Not Reported
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 5
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 17
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 179
- group Id
- BG003
- value
- 176
- group Id
- BG004
- value
- 377
- title
- Asian
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 74
- group Id
- BG003
- value
- 83
- group Id
- BG004
- value
- 165
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 23
- title
- Other
- title
- Race
- description
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 108
- group Id
- BG003
- value
- 107
- group Id
- BG004
- value
- 231
- title
- Asian, not specified
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 71
- group Id
- BG003
- value
- 69
- group Id
- BG004
- value
- 146
- title
- Chinese
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 99
- group Id
- BG003
- value
- 100
- group Id
- BG004
- value
- 207
- title
- Other ethnic population (Non-Asian)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- title
- Missing
- title
- Ethnic Population
- description
- Ethnic population
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The Safety Run-In treatment arms are based on the Safety set, which includes all participants allocated to the safety run-in group of this study and who receive at least 1 dose of study treatment (Osimertinib, Cisplatin, Carboplatin, or Pemetrexed). The Randomized treatment arms are based on the Full Analysis set, which includes all participants allocated to the randomized group of this study and who were randomized to a treatment arm.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 279
- group Id
- BG003
- value
- 278
- group Id
- BG004
- value
- 587
- units
- Participants
- groups
- description
- Osimertinib (AZD9291) 80 mg once daily (QD) with Carboplatin (AUC of 5 mg/mL/min \[AUC5\]) and Pemetrexed (500 mg/m2), both administered every 3 weeks (Q3W) for 4 cycles, followed by Osimertinib 80 mg once daily plus Pemetrexed maintenance (500 mg/m2) Q3W
- id
- BG000
- title
- Safety Run-In: AZD9291 + Carboplatin + Pemetrexed
- description
- Osimertinib (AZD9291) 80 mg once daily (QD) with Cisplatin (75 mg/m2) and Pemetrexed (500 mg/m2), both administered every 3 weeks (Q3W) for 4 cycles, followed by Osimertinib 80 mg once daily plus Pemetrexed maintenance (500 mg/m2) Q3W
- id
- BG001
- title
- Safety Run-In: AZD9291 + Cisplatin + Pemetrexed
- description
- Osimertinib (AZD9291) 80 mg in combination with pemetrexed (500 mg/m2) plus either cisplatin (75 mg/m2) or carboplatin (AUC5) on Day 1 of 21-day cycles for 4 cycles, followed by Osimertinib (AZD9291) 80 mg QD with Pemetrexed maintenance (500 mg/m2) Q3W
- id
- BG002
- title
- Randomized: AZD9291 + Chemo
- description
- Osimertinib (AZD9291) 80mg QD.
- id
- BG003
- title
- Randomized: AZD9291
- description
- Total of all reporting groups
- id
- BG004
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.82
- value
- 62.4
- group Id
- BG001
- spread
- 8.36
- value
- 60.4
- group Id
- BG002
- spread
- 10.03
- value
- 61.0
- group Id
- BG003
- spread
- 10.57
- value
- 60.7
- group Id
- BG004
- spread
- 10.3
- value
- 60.9
- title
- Age (Years)
- description
- Age in Years at study entry
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 44
- group Id
- BG004
- value
- 88
- title
- <50
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 136
- group Id
- BG003
- value
- 122
- group Id
- BG004
- value
- 270
- title
- >=50-<65
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 82
- group Id
- BG003
- value
- 88
- group Id
- BG004
- value
- 179
- title
- >=65-<75
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 24
- group Id
- BG004
- value
- 50
- title
- >=75
- title
- Age Group
- description
- Age Groups in Years at study entry
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 173
- group Id
- BG003
- value
- 169
- group Id
- BG004
- value
- 361
- title
- Female
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 106
- group Id
- BG003
- value
- 109
- group Id
- BG004
- value
- 226
- title
- Male
- title
- Sex
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 29
- group Id
- BG004
- value
- 68
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 239
- group Id
- BG003
- value
- 248
- group Id
- BG004
- value
- 517
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- group Id
- BG004
- value
- 2
- title
- Unknown or Not Reported
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 3
- group Id
- BG004
- value
- 5
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- group Id
- BG004
- value
- 0
- title
- Native Hawaiian or other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 11
- group Id
- BG003
- value
- 6
- group Id
- BG004
- value
- 17
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 179
- group Id
- BG003
- value
- 176
- group Id
- BG004
- value
- 377
- title
- Asian
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 74
- group Id
- BG003
- value
- 83
- group Id
- BG004
- value
- 165
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 10
- group Id
- BG004
- value
- 23
- title
- Other
- title
- Race
- description
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 108
- group Id
- BG003
- value
- 107
- group Id
- BG004
- value
- 231
- title
- Asian, not specified
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 71
- group Id
- BG003
- value
- 69
- group Id
- BG004
- value
- 146
- title
- Chinese
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 99
- group Id
- BG003
- value
- 100
- group Id
- BG004
- value
- 207
- title
- Other ethnic population (Non-Asian)
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 2
- group Id
- BG004
- value
- 3
- title
- Missing
- title
- Ethnic Population
- description
- Ethnic population
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The Safety Run-In treatment arms are based on the Safety set, which includes all participants allocated to the safety run-in group of this study and who receive at least 1 dose of study treatment (Osimertinib, Cisplatin, Carboplatin, or Pemetrexed). The Randomized treatment arms are based on the Full Analysis set, which includes all participants allocated to the randomized group of this study and who were randomized to a treatment arm.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle